Richard Pzena's position in Pfizer is currently worth $161M. That's 0.51% of their equity portfolio (38th largest holding). The first Pfizer trade was made in Q4 2014. Since then Richard Pzena bought shares nineteen more times and sold shares on 21 occasions. The investor's estimated purchase price is $214M, resulting in a loss of 25%.